Condition
Unresectable Pancreatic Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Unresectable Pancreatic Cancer clinical trials that are recruiting, at sites in 7 countries (most in Italy (2), China (2), South Korea (1)). By phase: Phase 2 (1), Phase 1/2 (1), Phase 1 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 7Countries
Newest Unresectable Pancreatic Cancer clinical trials
All recruiting trials (7)
-
Autologous neutrophils carrying MMAE for unresectable pancreatic cancer
This will test whether a patient's own neutrophils, loaded with the chemotherapy drug MMAE, can help shrink or control unresectable pancreatic cancer.
-
Evaluating NRT6008 for patients with advanced pancreatic cancer
This study is testing a new injection called NRT6008 to see if it is safe and effective for people with advanced pancreatic cancer that can't be removed by surgery.
-
Reducing severe neutropenia risk in patients with advanced pancreatic and bile duct cancers
This study is testing if a new medication can help people with advanced pancreatic and bile duct cancers avoid severe drops in their white blood cell count while they are getting chemotherapy.
-
Pancreatic enzyme capsules to help digestion and weight in people with unresectable pancreatic head cancer
This trial will test whether adding pancreatin (Creon) capsules to usual care helps digestion, weight, and nutrition in people with unresectable pancreatic head cancer who have significant weight loss and a dilated main pancreatic duct.
-
Intratumoral alpha-radiation seed implants for locally advanced pancreatic cancer
This trial will try tiny alpha-radiation seed implants placed directly into tumors to see if they are safe and feasible for adults with locally advanced, unresectable pancreatic adenocarcinoma who have already had or cannot tolerate more chemotherapy.
-
Using alpha radiation emitters to treat advanced pancreatic cancer
This study is testing a new type of radiation treatment for people with advanced pancreatic cancer to see if it can help shrink their tumors.
-
Using nanoparticles with MR-guided radiation therapy for lung and pancreatic tumors
This study is testing if a new type of nanoparticle can make radiation therapy more effective for people with lung tumors and advanced pancreatic cancer.
Related topics
Quick answers
How many Unresectable Pancreatic Cancer clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Italy (2 trials), China (2 trials), South Korea (1 trial), United States (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1, Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.